Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 318 shares at $423.73 ($135K) on 2026-05-04, disclosed to the SEC on 2026-05-05.
Scheduled sale ($135k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |
| VRTX | SELL | 2024-08-12 | $1.2M | — | Filing → |